Dublin, Jan. 16, 2019 (GLOBE NEWSWIRE) -- The "Global Artificial Organs Market: Focus on Organ Type, Technology Type, Competitive Landscape, Pipeline Products Data, and 12 Countries Data - Analysis and Forecast: 2018-2023" report has been added to ResearchAndMarkets.com's offering.

The global artificial organs market was estimated at $1.6 billion in 2017 and is anticipated to reach $5.37 billion by 2023. Among the different artificial organs available in the market, artificial ear contributed to the highest market share of the global artificial organs market in 2017. However, artificial pancreas is expected to witness the highest CAGR during the forecast period between 2018 and 2023.

The presence of several artificial pancreas products in the pipeline attributes to the highest CAGR displayed by the artificial pancreas market. Based on technology, implantable devices occupied higher market share as compared to wearable devices, whereas wearable devices demonstrated the potential to register higher growth rate than implantable technology.

The medical device industry is a multi-billion dollar market consisting of various verticals aimed at prolonging a patient's lives and improving the overall quality of lives. Foremost among the medical device innovation was the development of artificial organs as a substitute of organ transplants. Rapidly aging population worldwide and increased prevalence of lifestyle diseases have led to an increased number of people suffering from organ failures.

However, the unavailability of adequate organs and huge scarcity of organ donors have resulted in a global concern regarding organ shortage. Thousands of people die every year while waiting for some vital organ transplantation. The advent of artificial organs as the potential replacement of organ transplants has given a new ray of hope to resolve the organ shortage crisis. Artificial organs are man-made engineered devices that can mimic vital organ function of the body. It is either an implantable or a wearable medical device or a combination of two and is designed based on mechanical, optical, electrical, and biophysical properties of the living organs.

The market analysis of global artificial organs includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis. Presently, the artificial organs market can be categorized into five major organ types that are commercially available. It includes artificial pancreas, heart, ear, eye, and urinary bladder.

Considerable number of other artificial organs are presently in the pipeline, including artificial lungs, liver, kidney, and trachea that are expected to be commercialized in the upcoming years. Based on technology, the artificial organs market can further be sub-segmented into two broad categories: implantable devices and non-implantable devices.

Key Topics Covered:

Executive Summary

1 Market Overview
1.1 Introduction
1.2 Transplantation and Rising Need for Artificial Organs
1.3 The Widening Gap between Demand and Supply of Organs
1.4 Advent of Artificial Organs and Current Status
1.5 Impact of Artificial Organs: Advantages and Disadvantages
1.6 The Future of Artificial Organs
1.7 Global Market Scenario
1.8 Assumptions and Limitations

2 Market Dynamics
2.1 Overview
2.2 Impact Analysis
2.3 Market Drivers
2.3.1 Growing Geriatric Population
2.3.2 Rising Incidence of Lifestyle Diseases
2.3.3 Increasing Need for Organ Transplantation and Substantial Shortage of Available Donors
2.3.4 Persistent Support from Government and Non-Governmental Organizations
2.3.5 Technological Advancements and Increased R&D Expenditure
2.4 Challenges
2.4.1 Risks of Device Malfunction and Other Related Concerns
2.4.2 Immune Barrier to Artificial Organ
2.4.3 Stringent Regulation and Poor Reimbursement Coverage
2.4.4 Exorbitant Cost of Artificial Organs
2.5 Opportunities
2.5.1 Application of Advanced Biomaterials in Artificial Organs
2.5.2 Organ-on-Chips Technology
2.5.3 Monitoring Artificial Organs Using Precise Diagnostics

3 Competitive Landscape
3.1 Key Developments and Strategies
3.1.1 Product Approvals
3.1.2 Agreements, Collaborations and Partnerships
3.1.3 Funding
3.1.4 Product Launches and Developments
3.1.5 Acquisition
3.1.6 Other Strategies
3.1.7 Market Share Analysis
3.1.8 Growth Share Analysis (by Organ Type)
3.2 Industry Attractiveness
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New Entrants
3.2.4 Threat of Substitute Products
3.2.5 Intensity of Competitive Rivalry

4 Regulatory Framework
4.1 Legal Requirements and Framework at International Level
4.1.1 International Federation for Artificial Organs (IFAO)
4.1.2 World Health Organization (WHO)
4.2 Legal Requirements and Framework in the Americas
4.2.1 American Society for Artificial Internal Organs (ASAIO)
4.2.2 American Society of Transplantation (AST)
4.2.3 American Chemical Society (ACS)
4.2.4 United States Department of Health and Human Services (HHS)
4.3 Legal Requirements and Framework in Europe
4.3.1 European Society for Artificial Organs (ESAO)
4.3.2 European Society of Organ Transplantation (ESOT)
4.3.3 British Transplantation Society (BTS)
4.3.4 European Society for Bone Marrow and Transplantation (EBMT)
4.3.5 European Commission (EC)
4.4 Legal Requirements and Framework in Asia-Pacific
4.4.1 Asia-Pacific Society of Artificial Organs (ASPAO)
4.4.2 Organ and Tissue Authority (OTA)
4.4.3 Japanese Society for Artificial Organ (JSAO)
4.4.4 Society for Biomaterials and Artificial Organs

5 Global Artificial Organs Market (by Organ Type)
5.1 Overview
5.2 Artificial Pancreas
5.3 Artificial Heart
5.4 Artificial Ear
5.5 Artificial Eye
5.6 Artificial Urinary Bladder

6 Global Artificial Organs Market (by Technology)
6.1 Overview
6.2 Wearable Technologies
6.3 Implantable Technologies

7 Global Artificial Organs Market (by Region)
7.1 Global Artificial Organs Market: Analysis of Growth Potential of Different Countries
7.2 Global Overview
7.3 North America
7.3.1 The U.S.
7.3.2 Canada
7.4 Europe
7.4.1 Germany
7.4.2 The U.K.
7.4.3 France
7.4.4 Italy
7.4.5 Sweden
7.4.6 Rest-of-Europe
7.5 Asia-Pacific
7.5.1 Japan
7.5.2 China
7.5.3 Australia
7.5.4 India
7.5.5 Singapore
7.5.6 Rest-of-Asia-Pacific
7.6 Rest-of-the-World
7.6.1 Latin America
7.6.2 Middle East & Africa

8 Company Profiles

  • Advanced Bionics AG and affiliates
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • Dexcom, Inc.
  • Insulet Corporation
  • KeraMed, Inc.
  • MED-EL
  • Medtronic plc
  • Oticon Medical
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • SynCardia Systems, LLC
  • Tandem Diabetes Care, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/sgm4dj/global_artificial?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomaterials